MS
Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1526
Skyworks Solutions
SWKS
$11.1B
|
CH
Craig Hettenbach
| $74.68 | $114 |
53%
upside
| Equal-Weight |
7 Feb ‘23
2 years ago |
|
1527
Evercore
EVR
$13.3B
|
MG
Manan Gosalia
| $343.35 | $102 |
70%
downside
| Equal-Weight |
6 Feb ‘23
2 years ago |
|
|
LENZ
1528
LENZ Therapeutics
LENZ
$1.16B
|
JH
Jeffrey Hung
| $40.81 | $21 |
49%
downside
| Equal-Weight |
3 Feb ‘23
2 years ago |
|
1529
Becton Dickinson
BDX
$54.6B
|
DR
Drew Ranieri
| $190.56 | $295 |
55%
upside
| Overweight |
3 Feb ‘23
2 years ago |
|
1530
Thermo Fisher Scientific
TMO
$186B
|
DB
Daniel Brennan
| $491.41 | $670 |
36%
upside
| Overweight |
2 Feb ‘23
2 years ago |
|
1531
Otis Worldwide
OTIS
$35.1B
|
JP
Joshua Pokrzywinski
| $89.38 | $89 |
0%
downside
| Equal-Weight |
2 Feb ‘23
2 years ago |
|
1532
CACI
CACI
$10.8B
|
MS
Matthew Sharpe
| $493.12 | $357 |
28%
downside
| Overweight |
2 Feb ‘23
2 years ago |
|
1533
Booz Allen Hamilton
BAH
$12.8B
|
MS
Matthew Sharpe
| $103.84 | $116 |
12%
upside
| Overweight |
2 Feb ‘23
2 years ago |
|
1534
SEI Investments
SEIC
$10.9B
|
RK
Ryan Kenny
| $87.77 | $54 |
38%
downside
| Underweight |
1 Feb ‘23
2 years ago |
|
1535
Lennox International
LII
$19.9B
|
JP
Joshua Pokrzywinski
| $567.28 | $279 |
51%
downside
| Equal-Weight |
1 Feb ‘23
2 years ago |
|
1536
Rocket Pharmaceuticals
RCKT
$354M
|
MU
Michael Ulz
| $3.28 | $45 |
1,272%
upside
| Overweight |
1 Feb ‘23
2 years ago |
|
1537
Planet Fitness
PLNT
$8.68B
|
BH
Brian Harbour
| $103.43 | $92 |
11%
downside
| Overweight |
31 Jan ‘23
2 years ago |
|
1538
Celularity
CELU
$62.2M
|
JH
Jeffrey Hung
| $2.33 | $10 |
329%
upside
| Underweight |
30 Jan ‘23
2 years ago |
|
1539
Xilio Therapeutics
XLO
$37.8M
|
MU
Michael Ulz
| $0.7297 | $10 |
1,270%
upside
| Overweight |
27 Jan ‘23
2 years ago |
|
1540
Taysha Gene Therapies
TSHA
$884M
|
MU
Michael Ulz
| $3.24 | $3 |
7%
downside
| Equal-Weight |
27 Jan ‘23
2 years ago |
|
1541
Vir Biotechnology
VIR
$727M
|
MU
Michael Ulz
| $5.23 | $30 |
474%
upside
| Equal-Weight |
27 Jan ‘23
2 years ago |
|
1542
QuantumScape
QS
$5.01B
|
AJ
Adam Jonas
| $8.85 | $3 |
66%
downside
| Underweight |
25 Jan ‘23
2 years ago |
|
1543
GE Aerospace
GE
$299B
|
JP
Joshua Pokrzywinski
| $281.56 | $71.83 |
74%
downside
| Overweight |
25 Jan ‘23
2 years ago |
|
1544
Sana Biotechnology
SANA
$875M
|
MH
Matthew Harrison
| $3.40 | $13 |
282%
upside
| Overweight |
24 Jan ‘23
2 years ago |
|
1545
Lyell Immunopharma
LYEL
$256M
|
MH
Matthew Harrison
| $13.30 | $80 |
502%
upside
| Equal-Weight |
24 Jan ‘23
2 years ago |
|
1546
Bolt Biotherapeutics
BOLT
$10.1M
|
MH
Matthew Harrison
| $5.27 | $60 |
1,039%
upside
| Equal-Weight |
24 Jan ‘23
2 years ago |
|
1547
BioNTech
BNTX
$25.1B
|
MH
Matthew Harrison
| $104.31 | $216 |
107%
upside
| Equal-Weight |
24 Jan ‘23
2 years ago |
|
1548
ADC Therapeutics
ADCT
$375M
|
MH
Matthew Harrison
| $3.33 | $5 |
50%
upside
| Equal-Weight |
24 Jan ‘23
2 years ago |
|
|
ADAG
1549
Adagene
ADAG
$110M
|
MH
Matthew Harrison
| $2.34 | $5 |
114%
upside
| Overweight |
24 Jan ‘23
2 years ago |
|
1550
iQIYI
IQ
$2.52B
|
RX
Rebecca Xu
| $2.62 | $5.10 |
95%
upside
| Equal-Weight |
19 Jan ‘23
2 years ago |
|